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ABSTRACT
Poor femoral neck bone geometry at the femur is an important risk factor for hip fracture. We conducted a genome-wide association
study (GWAS) of femoral neck bone geometry, examining approximately 379,000 eligible single-nucleotide polymorphisms (SNPs) in
1000 Caucasians. A common genetic variant, rs7430431 in the receptor transporting protein 3 (RTP3) gene, was identified in strong
association with the buckling ratio (BR, P¼1.6 10
 7), an index of bone structural instability, and with femoral cortical thickness (CT,
P¼1.9 10
 6). The RTP3 gene is located in 3p21.31, a region that we found to be linked with CT (LOD¼2.19, P¼6.0 10
 4) in 3998
individuals from 434pedigrees. The replication analyses in1488independent Caucasiansand 2118Chinese confirmedthe association of
rs7430431 toBRandCT(combinedP¼7.0 10
 3forBRandP¼1.4 10
 2forCT).Inaddition, 350hipfracture patientsand350healthy
control individuals were genotyped to assess the association of the RTP3 gene with the risk of hip fracture. Significant association
between a nearby common SNP, rs10514713 of the RTP3 gene, and hip fracture (P¼1.0 10
 3) was found. Our observations
suggest that RTP3 may be a novel candidate gene for femoral neck bone geometry.  2010 American Society for Bone and Mineral
Research.
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Introduction
O
steoporosisisaskeletaldisorderthatischaracterizedbylow
bone strength and an increased risk of bone fracture. In the
United States, osteoporosis leads to 5.2 million fractures per
decade.
(1)Amongfracturesatvarious skeletalsites,hipfractureis
the most important owing to its high prevalence,
(2) high
mortality and morbidity,
(3) and excessive therapeutic cost.
(4,5)
The direct cost for hip fracture in the United State was around
$13.6 billion in 2005,
(6) and this expenditure is expected to
increase substantially owing to the population aging. An
important risk factor for hip fracture is reduced femoral neck
bone geometry at the proximal femur,
(7) which is largely
determined by low bone mineral density (BMD) and poor
femoral neck (FN) bone geometry.
(8,9) Prospective determination
of FN geometric parameters has significant potential to improve
the prediction of hip fracture substantially.
(10–12)
FN bone geometry is under strong genetic control.
(13–15)
Previous whole-genome linkage studies have identified several
chromosomal regions linked to FN geometry.
(13,15,16) These
linkage findings were inconclusive, however, requiring further
fine mapping studies because they identified relatively wide
genomic regions that typically contain hundreds of genes.
Although several candidate genes have been suggested by a
small number of association studies of human femoral
geometry,
(17–21) our current knowledge of genetic factors
underlying femoral geometry is relatively superficial.
Genome-wide association study (GWAS) has been used by
several research groups to successfully identify genetic factors
foranumberofcomplexdisorders.
(22–29)Currently,thisapproach
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320has been regarded as one of the most efficient and feasible
methods available to locate genes for complex diseases.
Recently, Kiel and colleagues
(30) conducted a pilot GWAS for
FN bone geometry parameters using the Affymetrix 100K SNP
GeneChip. Although several interesting regions were identified
in that study, some important genes may have escaped
detection owing to the relatively low coverage of the 100K
Affymetrix GeneChip. To improve our understanding of the
genetic basis of femoral bone geometry, we performed a GWAS
usinghighly denseAffymetrix500KSNParrays in1000Caucasian
subjects. We identified a novel gene, RTP3 (receptor transporting
protein 3), associated with two indices of FN bone geometry. The
gene’s importance to bone strength and osteoporosis was
assessedandconfirmedbyreplication inindependentCaucasian
and Chinese samples.
Materials and Methods
Subjects and measurements
The study was approved by the institutional review boards of all
involved institutions. Signed informed-consent documents were
obtained from all study participants before they entered the
study.
We first performed a GWAS (stage 1) in 1000 unrelated
Caucasian subjects for genes/regions important for FN bone
geometry. The most significant gene identified in stage 1 was
further studied in three additional unrelated Caucasian and
Chinese Han samples (stage 2). All samples studied, in both
stage 1 and stage 2, are independent. Table 1 presents basic
characteristics of the studied samples, with detailed information
as follows:
Caucasian GWAS sample and independent Caucasian
sample for within-ethnic group replication study
Instage1,fortheGWAS, 1,000unrelatedsampleswereidentified
from our established and expanding genetic repertoire currently
containing more than 6000 subjects. In stage 2, 1488 unrelated
samples were further selected from the remainder of our
established samples. All the chosen subjects were unrelated U.S.
Caucasians of European origin. Here, unrelated means there are
no family links among other subjects in the sample. The subjects
were recruited for genetic research by advertising. In the
recruitment, individuals with chronic diseases and conditions
that potentially might affect bone metabolism were excluded.
These diseases/conditions included chronic disorders involving
vital organs (e.g., heart, lung, liver, kidney, and brain), serious
metabolic diseases (e.g., diabetes, hypo- and hyperparathyroid-
ism, hyperthyroidism, etc.), other skeletal diseases (e.g., Paget
disease, osteogenesis imperfecta, rheumatoid arthritis, etc.),
chronic use of drugs affecting bone metabolism (e.g., hormone-
replacement therapy, corticosteroid therapy, anticonvulsant
drugs), and malnutrition conditions (e.g., chronic diarrhea,
chronic ulcerative colitis, etc.). In addition, subjects taking
anti-bone-resorptive or bone anabolic agents/drugs, such as
bisphosphonates, were excluded from this study. The purpose of
these exclusion criteria was to minimize the effects of environ-
mental and therapeutic factors to influence the skeletal system.
Minimizing the influence of these variables should provide for
relative augmentation of the effects of genetic factors in our
study sample, thereby improving our study design through
increased statistical power for detecting these genetic factors.
ArealBMD (g/cm
2)andregionarea(cm
2)ofFNweremeasured
using Hologic machines (Hologic, Inc., Bedford, MA, USA). The
machines were calibrated daily. The coefficient of variation (CV)
values of the DXA measurements for FN BMD and region area
were 1.87% and 1.97%, respectively.
Using DXA-derived FN BMD and region area, we estimated
two FN geometric variables. The algorithm and the underlying
assumptions regarding the geometry and structure of FN were
elaborated earlier.
(31,32) Briefly, the method assumes that (1)
bone within the FN region has the configuration of a uniform
circular cylinder, (2) 60% of the measured bone mass is cortical
(i.e., fc ¼0.6), and (3) the effective BMD in fully mineralized bone
tissue is 1.05g/cm
3 (i.e.,  m ¼1.05g/cm
3). All these assumptions
were substantiated as good approximations.
(31)
The estimated FN geometric variables are CT (cortical
thickness) and BR (buckling ratio)—an index for bone structural
stability. They are computed as follows:
BR ¼
W=2
CT
CT ¼
W   ED
2
Table 1. Characteristics of the Study Subjects
Stage 1: Caucasians Stage 2: Caucasians Stage 2: Chinese Stage 2: Chinese
GWAS
unrelated
Caucasians
Unrelated bone
geometry
sample
Unrelated bone
geometry
sample
Hip fracture sample
Case Control
Number 987 1488 2118 350 350
Sex ratio (M/F) 496/491 660/828 1119/999 124/226 173/177
Age (years) 50.35 (18.31) 54.97 (16.77) 28.17 (8.31) 69.35 (7.41) 69.54 (6.09)
Weight (kg) 80.14 (17.80) 80.93 (18.01) 57.09 (9.46) 59.15 (12.05) 59.61 (10.84)
Height (cm) 170.83 (9.74) 170.32 (9.77) 164.10 (7.68) 162.84 (8.31) 159.41 (9.20)
Buckling ratio 12.01 (2.74) 12.79 (2.63) 10.60 (1.82) ——
Cortical thickness (cm) 0.16 (0.03) 0.15 (0.03) 0.16 (0.02) ——
Note: Data presented are unadjusted means (SD).
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W
2
   2
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CSA
p
s
where W is the FN periosteal diameter and can be approximated
by dividing the region area of FN by the width of the region of
interest (in Hologic DXA systems, the width of the FN region is
standardized at 1.5cm).
(21) CSA (cross-sectional area) is
calculated as
CSA ¼
BMD W
rm
Chinese unrelated bone geometry sample
The 2118 unrelated Chinese subjects were healthy Chinese Han
adults living in Changsha City. As with the Caucasian samples,
Chinese subjects with chronic disorders involving vital organs,
seriousmetabolicdiseases,otherskeletaldiseases,chronicuseof
drugs affecting bone metabolism, and malnutrition conditions
were excluded from the study. Areal BMD (g/cm
2) and region
area (cm
2) of FN were measured using Hologic 4500W machines
(Hologic, Inc., Bedford, MA, USA) under the same strict protocols
used with the Caucasian sample. The CV of the DXA
measurements for FN BMD and region area were 3.43% and
2.33%, respectively. BR and CT were estimated under the same
method as those used for the Caucasians.
Chinese unrelated hip fracture sample
The Chinese unrelated hip fracture samples were recruited from
Xi’anCityorneighboringareas,whichismorethan1000kmfrom
Changsha City. It therefore was an independent Chinese cohort.
The sample consisted of 350 patients with osteoporotic hip
fracture (including 124 males and 226 females) and 350 healthy
normal control individuals (including 173 males and 177
females). Affected individuals with low-trauma hip fracture were
recruited between 2004 and 2007 from the affiliated hospitals
and their associated clinics of Xi’an Jiaotong University. Inclusion
criteria for cases were (1) age at hip fracture>55 years for both
male and female subjects and all women enrolled were
postmenopausal, (2) minimal trauma fractures, usually owing
to falls from standing height or less, (3) fracture site at FN or
intertrochanter, and (4) hip fracture was identified through
diagnosis of orthopedic surgeons/radiologists according to
radiologic reports or X-rays. Patients with pathologic fractures,
high-trauma fractures (such as motor vehicle accident), and late
complications of fractures of the proximal femur requiring a
second intervention were excluded. Control subjects were
enrolled with the following inclusion criteria: (1) age at
exam 60 years and (2) exclusion of subjects with chronic
diseases and conditions that potentially might affect bone mass,
structure, or metabolism (the exclusion criteria are the same as
those adopted in recruitment of Caucasian subjects).
Genotyping
Caucasian GWAS sample
Genomic DNA was extracted from whole human blood using a
commercial isolation kit (Gentra Systems, Minneapolis, MN, USA)
following the protocols detailed in the kit. Genotyping with the
Affymetrix Mapping 250K Nsp and Affymetrix Mapping 250K Sty
arrays was performed using the standard protocol recom-
mended by the manufacturer. Fluorescence intensities were
quantitated using Affymetrix Array Scanner 30007G. Data
management and analyses were performed using the Affymetrix
GeneChip Operating System. Genotyping calls were determined
from the fluorescent intensities using the dynamic modeling
(DM) algorithm with a 0.33 P-value setting,
(33) as well as
the Bayesian robust linear model with Mahalanobis distance
(B-RLMM) algorithm.
(34) DM calls were used for quality control,
whereas the B-RLMM calls were used for all subsequent data
analyses. B-RLMM clustering was performed with 94 samples per
cluster.
Following an Affymetrix guideline, we set a standard for the
minimum DM call rate at 93% for a sample, considering all the
single-nucleotide polymorphisms (SNPs) in the two arrays, the
250K Nsp and 250K Sty arrays. Eventually, 997 subjects who had
at least one array (Nsp or Sty) reaching a 93% call rate were
retained. Because of missing data for bone geometry pheno-
types among the 997 subjects, the effective sample size for the
GWAS was 987 for both BR and CT. The average call rate for the
987analyzedsubjectsreachedgreaterthan95%.Oftheinitialfull
setof500,568SNPs,wediscarded32,961SNPswithSNP-wisecall
rate greater than 95%, 36,965 SNPs with allele frequencies
deviating from Hardy-Weinberg equilibrium (HWE, P<.001), and
51,323 SNPs with minor allele frequency (MAF) less than 1%.
Therefore,thefinalSNPsetfortheGWAS scan contained379,319
SNPs,yieldingagenomicmarkerspacingofapproximately7.9kb
on average.
Caucasian bone geometry sample
Genomic DNA extraction and quality control procedures are the
same as those used for the GWAS sample. Genotyping of the
interesting SNPs identified from the GWAS in the Caucasian
unrelated sample was performed by KBioscience (Herts, UK)
using the technology of competitive allele-specific PCR (KASPar),
which is detailed at the company’s Web site (www.kbioscience.
co.uk). The replication rate (duplicate concordance rate) was
99.7% for genotyping, and the average call rate was 97.8%.
Chinese bone geometry sample
Genomic DNA was isolated from whole blood using the phenol-
chloroform extraction method. The concentration of DNA was
quantified using a DU530UV/VIS Spectrophotometer (Beckman
Instruments, Fullerton, CA, USA). The same set of SNPs used for
the Caucasian bone geometry sample was successfully geno-
typed in the Chinese bone geometry sample of 2118 subjects.
Genotyping was performed using a primer extension method
with MALDI-TOF mass spectrometry for multiplexed genotyping
of SNPs on a MassARRAY system, as suggested by the
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described by Braun and colleagues.
(35) The replication rate
was 99.2%, and the average call rate was 97.2%.
Chinese hip fracture sample
Genomic DNA extraction methodology was the same as that
used with the Chinese bone geometry sample. The 350 hip
fracturecasesand350controlsweregenotypedusingAffymetrix
Mapping 250K Nsp and Affymetrix Mapping 250K Sty arrays. The
final mean B-RLMM call rate reached a level of 99.02%, and
the duplication rate was 99.70%. The discordant genotypes
were discarded. Genotypes of interesting SNPs in this cohort
were obtained from the Affymetrix 500K chips.
Statistical analyses
In all four group samples (i.e., Caucasian GWAS, Caucasian bone
geometry, Chinese bone geometry, and Chinese hip fracture
cohorts),HWEwasassessedbychi-squareanalyses.SNPsthatdid
not follow HWE were excluded from further data analyses.
For the stage 1 Caucasian GWAS sample, parameters such as
age, age
2, sex, age/age
2-by-sex interaction, height, and weight
were tested for their associations with BR and CT using stepwise
regression. Significant (P .05) terms were included as covari-
ates to adjust the raw BR and CT values for subsequent analyses.
For BR, the covariates were age, height, weight, sex, and
age
2 sex. For CT, the covariates were age, weight, and age
2.
The residuals from a linear model after adjusting for the
significant covariates were used as traits in the follow-up data
analyses. To minimize possible spurious associations owing to
potential population stratification, we used EIGENSTRAT
(36)
software in GWAS association analyses. EIGENSTRAT detects
and corrects for ancestry information while performing associa-
tion analyses between phenotypes and genotypes. We used
EIGENSTRAT because it can appropriately handle the quantita-
tive data while maintaining sufficient power and robustness.
(36)
In the data analyses, the SNPs were coded as 0, 1, and 2 to
represent AA, AB, and BB genotypes.
Multiple testing is a perplexing issue in GWAS. Because the
Bonferroni correction is considered overly conservative given
extensive linkage disequilibrium (LD) among markers, we
adopted the GWAS significance threshold of approximately
4.2 10
 7 proposed by Lencz and colleagues.
(37) The gene-wise
approachused to calculate this threshold tookinto account recent
estimates of the total number of genes in the human genome.
The LD patterns of the most significant gene were analyzed
and plotted using the Haploview program
(38) (www.broad.
mit.edu/mpg/ haploview/). Focused association analyses on
certain SNPs and other miscellaneous statistical analyses were
performed using software packages SAS (SAS Institute, Inc., Cary,
NC, USA) and Minitab (Minitab, Inc., State College, PA, USA),
which include descriptive statistics data analysis and multiple
regression analysis to screen significant covariates for BR and CT
and the normality of the adjusted BR and CT data.
For stage 2 replication analyses of the significant gene,
significant parameters (P<.05) such as age, age
2, sex, age/age
2-
by-sex interaction, height, and weight were used as covariates to
adjust for the raw BR and CT values. We used a stepwise
regression model to screen significant covariates for each study
cohort. Since the effects of these confounding factors on the
traits were different in each cohort, different covariates were
applied. For unrelated bone geometry Caucasian samples
(n¼1488), the covariates were age, sex, age sex, weight,
and height for BR; weight, age
2, age
2 sex, and age sex for CT.
For unrelated Chinese bone geometry samples (n¼2118), the
covariates were age
2, weight, height, and age
2 sex for BR and
weight, age sex, age, and sex for CT. The residuals from a linear
regression model after adjusting for the significant covariates
were used as traits in the in HelixTree (www.goldenhelix.com/
SNP_Variation/HelixTree/index.html). The SNPs were coded
numerically with 0 for AA, 1 for AB, and 2 for BB, respectively.
In the replication stage, in order to account for the multiple-
testing problem, the SNPSpD method
(39) (http://gump.qimr.
edu.au/general/daleN/SNPSpD/) was adopted to infer the
effective number of independent tests (Meff), and the overall
significance level was set at 0.05/Meff.
The P values from cohorts of Chinese and Caucasian samples
for bone geometry were combined using Fisher’s method
(40) to
quantifytheoverallevidenceforassociationwithbonegeometry
variation. No cohort/geography adjustment was performed
because the tests for Caucasian and Chinese are independent
and have the same null hypotheses. In the Chinese hip fracture
sample, genotype distributions for SNPs were compared using
logistic regression models controlling for sex, age, height, and
weight as covariates between the fracture versus nonfracture
pooling sample including both males and females.
To detect population stratification that may lead to spurious
association results, we used the software Structure 2.2 (http://
pritch.bsd.uchicago.edu/software.html) toinvestigate the poten-
tial substructure/stratification of our sample. The Structure 2.2
program uses a Markov chain Monte Carlo (MCMC) algorithm to
cluster individuals into different cryptic subpopulations on the
basis of multilocus genotype data.
(41) Using the software, we
performed independent analyses under an assumption of K¼2
population strata using 200 unlinked markers in the GWAS
unrelated Caucasian cohort and 1000 unlinked markers in the
Chinese hip fracture cohort.
Results
GWAS in the Caucasian sample
Using EIGENSTRAT, which controls for potential population
stratification, we performed a genotype association analysis. For
all the analyzed SNPs and bone geometry phenotypes, we
observed one SNP (rs7430431) beyond the GWAS significant
threshold for BR (P¼1.61 10
 7; Table 2). This SNP also was
found to have a highly suggestive association with FN CT
(P¼1.92 10
 6). SNP rs7430431 is located in 3p21.31, a region
that we previously found to be linked with CT (LOD¼2.19,
P¼.0006) in 3998 individuals from 434 pedigrees.
(16) The minor
allele frequency (MAF) of rs7430431 was 49.4% according to our
data and 48.3% according to the HapMap CEU database (see
Table 2). The SNP was in HWE and located in the intron of the
RTP3 gene. The RTP3 gene, which has a total length of
approximately 3kb, contains two exons and one intron. In this
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rs7430431, most other SNPs in the region also achieved highly
suggestive association with both BR and CT (P   .001; see
Table 2). We selected 21 SNPs (see Table 2) within and adjacent
to RTP3 to reconstruct the LD block using Haploview in order to
further study this gene. Four blocks were reconstructed (Fig. 1).
Haplotype data analysis indicated that haplotype block 3,
containing rs7430431 has a highly suggestive association with
BR (P¼5.76 10
 5) (see Fig. 1). We also compared adjusted BR
and CT values between different genotypes of SNP rs7430431. In
our GWAS subjects, as shown in Fig. 2, subjects with the CC
genotype had the highest BR [12.54 0.15 ( SE)] and the lowest
CT (0.151 0.001cm), individual of CT genotype had inter-
mediate BR (12.02 0.10) and CT (0.155 0.001cm), and
individuals of the TT genotype had the lowest BR
(11.59 0.14) and the highest CT (0.159 0.001cm). Thus
rs7430431 genotypic effects on BR and CT are approximately
additive (Fig. 2). In our study subjects, individuals with the CC
genotype had, respectively, approximately 8.2% higher BR and
5.0% lower CT than those with the TT genotype, which
consistently leads to poor femoral neck bone geometry.
Replication studies in independent Caucasian and
Chinese samples
ReplicationstudiesconfirmedtheassociationoftheRTP3geneto
BR, CT, and hip fracture (Table 3). According to the HapMap-HCB
(Han Chinese in Beijing) database, the MAF of SNP rs7430431 is
less than 5% (4.4%), indicating a significant MAF difference
between Chinese and Caucasian samples. In addition to
rs7430431, SNP rs10514713 was selected for further analysis
in order to ensure high heterozygosity of the SNPs for replication
studies and therefore increase statistical power. SNP rs10514713
is in high LD with rs7430431 and is located in the 30UTR of the
RTP3 gene. There was evidence for association between
rs7430431 and both BR (P¼.020) and CT (P¼.020) in an
independent sample of 1488Caucasians. An association also was
detected between BR and rs7430431 (P¼.040) and rs10514713
(P¼.049) (see Table 3) in 2118 unrelated Chinese. A combined
association analysis using Fisher’s method showed that
rs7430431 was significantly associated with both BR (P¼.007)
and CT (P¼.014) (see Table 3). Further, the direction of this
association is the same as that in the original GWAS Caucasian
sample; i.e., C-allele carriers had higher BR and lower CT values
than T-allele carriers.
We tested two SNPs (SNPs rs10514713 and rs7430431) and
two phenotypes (BR and CT) in our replication study. These tests
resulted in a multiple-testing problem. In order to adjust for
multiple testing, we used the SNPSpD method to set the overall
significance level. The Meff for BR and CT phenotypes is 1.357, and
the Meff forthetwotestedSNPs(SNPsrs10514713andrs7430431)
is 1.515. Thus the significant threshold for the replication stage is
set at P¼.05/(1.357 1.515)¼0.024. According to the threshold,
most of our nominal significant results (P<.05) in Table 3 survive.
Table 2. Information for the 21 Analyzed SNPs Within and Adjacent to the RTP3 Gene and Their Association Results in GWAS Analysis
Using EIGENSTRAT
SNP ID Name Position Gene Role Allele
a MAF
b MAF
c P value for BR P value for CT
1 rs2269436 46462257 LTF Intron G/A 0.042 0.042 2.38 10
 1 2.87 10
 1
2 rs17141154 46462271 LTF Intron A/G 0.167 0.167 1.74 10
 3 6.21 10
 4
3 rs17078863 46473920 LTF Intron C/T 0.045 0.042 5.02 10
 1 3.05 10
 1
4 rs7629657 46474176 LTF Intron T/C 0.048 0.042 4.89 10
 1 2.95 10
 1
5 rs9862388 46479320 LTF Intron G/A 0.300 0.267 2.38 10
 1 2.87 10
 1
6 rs1520483 46485213 RTP3 Promoter T/C 0.350 0.374 1.81 10
 4 7.14 10
 4
7 rs7639243 46488981 LTF Promoter A/C 0.400 0.333 2.32 10
 1 2.21 10
 1
8 rs7641783 46489276 RTP3 Promoter T/C 0.273 0.258 4.06 10
 4 6.56 10
 5
9 rs883739 46513022 RTP3 Promoter A/C 0.352 0.375 4.99 10
 5 8.87 10
 5
10 rs7430431 46516151 RTP3 Intron C/T 0.494 0.483 1.61T10
 7 1.92 10
 6
11 rs11130094 46516507 RTP3 Intron A/G 0.404 0.364 1.03 10
 3 2.49 10
 4
12 rs10514713 46518621 RTP3 30 UTR A/C 0.380 0.381 2.68 10
 4 3.09 10
 4
13 rs7371865 46524192 RTP3 30 UTR A/C 0.105 0.075 2.49 10
 1 1.93 10
 1
14 rs1879328 46543161 LRRC2 Intron G/A 0.167 0.140 8.10 10
 1 8.40 10
 1
15 rs6791703 46544725 LRRC2 Intron G/T 0.498 0.500 8.69 10
 7 1.80 10
 4
16 rs939421 46551085 LRRC2 Intron G/A 0.300 0.225 4.90 10
 2 1.60 10
 1
17 rs11705987 46559076 LRRC2 Intron C/A 0.210 0.246 7.54 10
 2 5.40 10
 2
18 rs9810340 46559176 LRRC2 Intron T/A 0.450 0.458 5.33 10
 7 7.70 10
 5
19 rs9846026 46563817 LRRC2 Intron A/C 0.100 0.078 2.86 10
 2 3.90 10
 1
20 rs9808967 46564298 LRRC2 Intron T/A 0.050 0.076 3.03 10
 3 9.17 10
 2
21 rs11919651 46568910 LRRC2 Intron C/A 0.180 0.158 3.71 10
 2 4.60 10
 2
Note: The RTP3 gene is located in 3p21.31. MAF¼minor allele frequency; BR¼buckling ratio; CT¼cortical thickness.
aThe former allele represents the minor allele of each locus.
bMinor allele frequency calculated in our own Caucasian sample.
cMinor allele frequency reported for Caucasians in the public database such as Hap Map or dbSNP.
dP values were calculated using EIGENSTRAT analyses. Significant results at the GWAS level are labeled in bold.
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risk, we tested the association of the two SNPs with osteoporotic
hip fracture in a Chinese sample consisting of 350 hip fracture
patients and 350 healthy controls. A significant association was
found between SNP rs10514713 (MAF¼42.9%) and hip fracture
(P¼.001; see Table 3).
Discussion
Our GWAS and follow-up validation/replication studies in
independent Caucasian and Chinese samples identified RTP3
as a potential novel gene associated with variation of BR and CT
at the FN. BR and CT are geometric variables associated with hip
fracture.
(31,32,42) BR is an index for bone structural instabil-
ity
(31,43,44) and is positively associated with hip fracture. CT is
proportional to volumetric and areal BMD with the assumption
that the bone within the FN region is a uniform circular cylinder.
CT is negatively correlated with hip fracture risk.
(31,42) These two
geometric measures are highly correlated with one another and
have been reported as important predictors of the incidence of
hip fracture.
(12,31,45–47) In addition to BR and CT, in the current
GWAS of 987 unrelated Caucasian subjects using 379,000 SNPs,
we also tested other bone geometric measures, such as CSA and
Fig. 1. Schematic view of association results, marker density, and LD structure within and adjacent to the RTP3 gene. (A) Genome-wide association study
(GWAS) results for both single-marker and LD-block haplotype (solid line) association results. The SNP rs7431430 achievedthe most significant association
withBR (P¼1.61 10
 7). Block3 achieveda highlysuggestiveassociation withBR (P¼5.76 10
 5).RTP3¼receptor(chemosensory) transporter protein
3; LRRC2¼leucine-rich repeat containing 2; LTF¼lactotransferrin; CCRL2¼chemokine (C-C motif) receptor-like 2; ALS2CL¼ALS2 C-terminal like. (B) Gene
structureandLDpatternsforthe21SNPswithinoradjacenttotheRTP3geneinGWASCaucasiansamples.Exonsaredepictedwithaverticalbar.Positions
of the 21 SNPs (listed in Table 2) are sketched. LD block structure, as depicted by Haploview, is shown in the bottom frame. The increasing degree of
darkness from white to black represents the increasing strength of LD (measured by r
2).
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known genes reached the GWAS significance threshold
(4.2 10
 7). Since four FN geometry phenotypes are tested in
the data analyses and our threshold (4.2 10
 7) may need to be
adjusted. We did not adopt a more stringent threshold for the
following reasons: (1) We are reporting the most significant
results, and the results have been replicated in other
independent cohorts, especially in hip fracture cohorts. A
stringent GWAS threshold will not change our results. (2) The
four phenotypes are highly correlated, and a Bonferroni
correction will be too conservative for the study.
It should be noted that bone geometry phenotypes are
dependent on body size and shape.
(48) In our study, although
height and weight were used as covariates to adjust size
variation, the adjustment cannot totally remove the body size
and body shape effect. Currently, there is no established
appropriate method to correct body size and body shape effect.
The powerful GWAS analyses reported here identified an
intronic polymorphism (rs7430431) in the RTP3 gene as an SNP
that was significantly associated with BR variations. Since
rs7430431 has a low MAF in Chinese samples, we tested
rs7430431 plus a nearby common SNP of the RTP3 gene in our
replication studies with independent Caucasian and Chinese
samples. These replication analyses confirmed the association
between the RTP3 gene and BR. Importantly, the relevance of
the RTP3 gene to hip fracture risk also was detected in an
independent Chinese sample containing 700 subjects. Since
association results may be biased by population stratification, we
analyzed for potential population stratification for the cohorts
using software Structure 2.2
(41) in a GWAS unrelated Caucasian
sample and hip fracture sample. All subjects in the two cohorts
were tightly clustered together, suggesting no population
stratification.
The RTP3 gene is located at 3p21. This genomic region was
reported to be linked with CT (LOD¼2.19, P¼.0006) in our prior
linkage study performed in 3998 individuals from large
pedigrees.
(16) CT is an estimate with an assumption that a
60% of cortical mass is uniformly distributed in the femoral neck
region. BMD is an estimate of bone mineral uniformly distributed
in a region of interest. Since CT and BMD are highly correlated,
we also checked the importance of the 3p21 region for BMD
variation. A recent meta-analysis of BMD linkages
(49) failed to
identify this region as an important quantitative trait locus
(QTL). However, some independent linkage studies support
the concept that 3p21 is an important region for FN and spine
BMD variations.
(50–53) In 155 osteoporotic families containing
654 study individuals, Duncan and colleagues reported that
the 3p21 region achieved a suggestive LOD score for FN BMD
(LOD¼2.7).
(50) In addition, a study involving nonidentical twin
pairs (in 1094 pedigrees) detected a suggestive LOD score of 2.7
at chromosome 3p21 for spine BMD.
(52)
We referred to other reported GWAS in the bone field to look
for support for the association of the RTP3 gene and FN bone
geometry. Among them,
(28–30,54) FN bone geometry results are
only reported in the Framingham study,
(30) which provides
strong, independent support for our finding.
(30) In the National
Center for Biotechnology Information (NCBI) dbGaP database
(www.ncbi.nlm.nih.gov/sites/entrez?db¼gap), two SNPs (SNP9
rs883739 and SNP12 rs10514713 in Table 2) in the RTP3 gene,
which are in high LD with rs7430431 (r
2¼0.641 between SNP9
rs883739 and SNP10 rs7430431 and r
2¼0.638 between SNP12
rs10514713 and SNP10 rs7430431 in HapMap-CEPH), were
genotyped in the Framingham 100,000 GWAS. In the Framing-
ham study, both SNP9 rs883739 and SNP12 rs10514713 were
significantly associated with FN BR (P¼.030 and P¼.017,
respectively) in women.
RTP3 is a novel gene first identified in 2002. Several lines of
evidence support the concept that RTP3 may functions as a
tumor suppressor gene.
(55–57) In addition, the RTP3 protein
product shares homology with other RTP family members, which
have been shown to contribute to functional cell surface
expression of olfactory receptors on olfactory neurons. However,
in contrast to RTP1 and RTP2, RTP3 is not expressed in olfactory
neurons. Therefore, it appears unlikely that RTP3 influences
olfactioninamannersimilartothatdescribedforothermembers
of the RTP family.
(58) It is unknown whether RTP3 has other
biologic functions.
Fig. 2. Least square means (  SE) of BR and CT values in the three
genotypes of SNP rs7430431 in the unrelated GWAS Caucasian subjects.
A linear regression model was used with age, age
2, sex, age/age
2-by-sex
interaction, height, and weight as covariates. P values of one-wayANOVA
for testing the genotype effects on adjusted BR and CT are given.
Table 3. Replication Association Results in Stage 2
dbSNP rs7430431 rs10514713
Role Intron 30 UTR
Alleles C/T A/C
Unrelated bone geometry Caucasian sample (1488)
MAF .409 .335
P value for BR .020 .135
P value for CT .020 .198
Unrelated Chinese bone geometry sample (2118)
MAF .026 .486
P value for BR .040 .049
P value for CT .098 .093
Combined Chinese and Caucasians (3606)
P value for BR .007 .040
P value for CT .014 .092
Unrelated Chinese hip fracture sample (700)
MAF .020 .429
P value for hip fracture 0.308 .001
Note: Stage 2 involved a total of 3606 subjects for replication analysis
for BR and CT and 700 subjects for analysis for hip fracture. There is no
overlap between these samples. P values were one-tailed. The combined
P values were obtained based on Fisher’s method.
(40) No cohort/geo-
graphy is adjusted. The results with P<.05 are in bold. MAF¼minor
allele frequency; BR¼buckling ratio; CT¼cortical thickness.
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RTP3 gene to femoral neck bone geometry. However, the
mechanism by which it contributes to femoral neck bone
geometry and osteoporotic fracture risk is unknown. It has been
suggestedthatRTP3mayinteractwithFHIT(fragilehistidinetriad
gene), which downregulates the SMAD4 (SMAD family member
4) gene.
(59–62) SMAD4 is a transcription corepressor for the ESR1
(estrogen receptor alpha) gene and strongly inhibits the
transcription of various downstream genes of estrogen signal-
ing.
(63) Further, it has been shown that SMAD4 has direct physical
interactions with ESR1 and serves as a common signal transducer
in the bone morphogenetic protein (BMP)/transforming growth
factor-beta (TGF-b) signaling pathway.
(64,65) Both estrogen
signaling and BMP/TGF-b signaling pathways are important
for bone development and skeleton morphogenesis.
(66,67)
Furthermore, SMAD4 may directly regulate endochondral bone
formation,
(68) cartilage growth,
(69) bone healing,
(70) osteogen-
esis,
(71)and long bonedevelopment.
(72) Takentogether, our study
suggests that RTP3 may be a novel candidate gene influencing
bone geometry variation, potentially via FHIT and SMAD4.
Several limitations of our studies need to be mentioned. First,
the unrelated Chinese bone geometry sample was much
younger than the discovery cohort and other replication
samples. In our study, although age was used as a covariate
to adjust the raw BR and CT values, the adjustment may not
totally eliminate the age-related difference between groups.
Therefore, our replication result may suggest that the RTP3 gene
is important for femoral neck bone geometry in both young and
old population. Second, different genotyping methods were
used for different replication studies owing to different
genotyping platforms across the cooperative laboratories. Since
all the genotyping methods had high call and replication rates,
disparity of the genotyping methods should be acceptable. In
actuality, it is common to see the issue of varying genotyping
methods arise in GWAS replication studies. For example, Luciano
and colleagues used KASPar, MALDI-TOF, and Taqman genotyp-
ing methods in their replication studies.
(73) With the develop-
ment of genotyping technology, the concordant rate among
different genotyping methods (including MALDI-TOF and
KASPar) can be as high as 94% and even greater than
99.9%.
(74,75) Third, although the most significant SNP
(rs7430431) was consistently associated with BR in all bone
geometry replication studies, no evidence of association was
detected between rs7430431 and hip fracture. This may be
attributable to the low MAF (MAF¼0.02) of this SNP in the
Chinese hip fracture sample. The significant association of a
nearby common SNP (rs10514713) (MAF¼42.9%) with hip
fracture(P¼.001)providessupportiveevidenceforthepotential
importance of the RTP3 gene to the risk of hip fracture. Fourth,
although SNPs rs10514713 and rs7430431 are tested to be
important for bone geometry variation, without a functional
study, it is difficult to assert their importance. Without further
functional study, it is also difficult for us to confirm the
importance of RTP3 in bone development at early ontogenesis
and its outcomes later in the life. Fifth, our bone geometry
estimates, based on the earlier work,
(21,31,32,76) relied on the
assumptions of FN shape as a uniform circular cylinder. This
assumption may not be completely realistic.
(32)
In summary, for the first time, our GWAS identified a novel
gene, RTP3, significantly associated with bone femoral geometry.
The gene’s relevance to hip fractures and femoral neck bone
geometry was further replicated and confirmed in independent
Caucasian and Chinese samples. Our findings suggest that RTP3
may be a promising candidate gene for osteoporotic fractures in
different ethnic groups. Various further analyses, such as
replication in other ethnic populations and molecular functional
studies, are needed to validate this finding and delineate the
mechanism by which this gene influences femoral neck bone
geometry and fracture risk.
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